Archive for October, 2006
Edition for October 31, 2006
Welcome to the October 31, 2006 edition of carnival of depression, bipolar disorder, and mental health journeys!
Thanks to everyone for submitting your entries. Therapy Doc Linda Freedman asked an excellent question about bipolar disorder, putting some reality behind a “romanticized” notion of this devastating mental illness. I know people whose families were torn apart [...]
Seroquel Approved to Treat Manic and Depressive Episodes in Bipolar Disorder
Seroquel or quetiapine fumarate (manufactured by AstraZeneca) has received US FDA approval to treat both depressive and manic episodes associated with bipolar disorder. The benefit of one medication that can treat both the depressive and manic symptoms is that patients can adhere to (comply with) the medication regimen more easily. On the other hand, patients’ [...]
Blog Carnival October 17, 2006 Edition
Check out what you have submitted so far to the October 17, 2006 edition of carnival of depression, bipolar disorder, and mental health journeys. As you send new entries I will update this carnival. Thanks for everyone who have contributed!
This Week in Mental Health Research
Newer Not Necessarily Better. An October 2006 issue of Archives of General Psychiatry has published a report that suggests second-generation (”newer”) antipsychotic medications offered little advantage over older drugs for schizophrenic patients, which runs counter to a wide belief that newer antipsychotic agents are safer and more effective. Based on this study’s findings, justification for [...]
Blog Carnival October 3, 2006 Edition
Welcome to the October 3, 2006 edition of Carnival of Depression, Bipolar Disorder, and Mental Health Journeys.
depression
Steve Woodruff presents Clearing Clouds posted at Steve Woodruff, saying, “At first, it was like walking out on a frozen pond. You gingerly put a foot forward, and silently ask, “Will it hold me?” Waking up in the morning [...]
Corlux Not Meeting Study Goals for Psychotic Major Depression
Corcept Therapeutics’ lead drug, Corlux is being studied for its ability to reduce the psychotic symptoms of major depression in patients. Corlux is a Glucocorticoid receptor type II (GRII) antagonist and may be better “known” as the controversial mifepristone (or RU-486, otherwise known as the “morning after” pill). The company initiated studies on Corlux based [...]
Lamictal and Birth Defects
The US Food and Drug Administration has issued an alert about Lamictal (lamotrigine) that suggests that babies exposed to the drug during the first trimester in pregnancy may have a higher chance of being born with a cleft lift or cleft palate. Additional research is needed to establish further evidence of this observation and this [...]
All information in Jane's Mental Health Source Page website is for your information and education. The information does not replace or substitute for professional medical treatment or for professional medical advice relative to a specific medical question or condition.
recent comments